Contact this trialFirst, we need to learn more about you.
Nucleoside Analog
Decitabine + FLAG-Ida for Myeloid Malignancies
Recruiting1 awardPhase 1 & 2
Seattle, Washington
This trial is testing a new treatment for adult patients with certain types of blood cancers, including acute myeloid leukemia, myelodysplastic syndrome, and chronic myelomonocytic leukemia
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service